Care For The Cancer Caregiver: A Meaning-Based Workshop To Help Manage Caregiver Burden
1 other identifier
interventional
88
1 country
1
Brief Summary
The purpose of this study is to gather information on how easy it is to implement the workshop, as well as whether individuals find this workshop helpful. In this study, participants will be assigned at random to one of the two study groups. Based on the information we obtain, we hope to develop an easily accessible support service for caregivers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 24, 2014
CompletedFirst Posted
Study publicly available on registry
September 26, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedAugust 10, 2018
August 1, 2018
3.9 years
September 24, 2014
August 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
feasibility of this novel approach
which will be measured by our ability to recruit our target sample and the proportion of participants who complete the CCC Workshop. Additional indices related to this aim (acceptability) will be gathered via both quantitative (entire sample) and qualitative (with a subset of participants randomized to received the CCC Workshop) methods.
2 years
Study Arms (2)
This web-based CCC Workshop
EXPERIMENTALThe Care for the Cancer Caregivers (CCC) workshop is composed of six webcasts. The Introductory Webcast is based upon Sessions 1 and 2 of Meaning-Centered Psychotherapy for Cancer Caregivers (MCP-C) and provides participants with an introduction to the CCC Workshop, an overview of the different meaning-centered modules (i.e., legacy, choice, creativity, and connectedness), and a discussion about identity and how caregivers' identities have or have not changed since taking on this role.
Waitlist Control
ACTIVE COMPARATORParticipants randomized to the waitlist control arm will be offered what is considered "usual care" at the ACS: the provision of the ACS Telephone Hotline number (1-800- 227-2345) and direction to the ACS website (www.cancer.org) where participants can find many resources for caregivers, including links to the ACS Caregiver ToolKit. They will complete assessments at time points that correspond with the completion of assessments in the CCC Workshop arm: after consent as soon as they are able (T1), about 2 months (± 4 weeks) after T1 (T2), and about 2-3 months after T2 (T3). Upon completion of all study assessments the waitlist control arm participants will be offered the opportunity to complete the CCC Workshop.
Interventions
Eligibility Criteria
You may qualify if:
- As per self report, a current caregiver to a patient with any site or stage of cancer
- Age 18 or over
- A score of \> 4 on the Distress Thermometer (DT) and indication that this distress is related in some way to the caregiving role
- In the judgment of the investigators and/or consenting professional, able to comprehend English to complete study assessments
- Able to perform informed consent
- Enrollment is open to caregivers with their own current/past cancer histories
You may not qualify if:
- Significant psychiatric or cognitive disturbance sufficient, in the investigator's judgment, to preclude providing informed consent.
- As per self report, unable to access a computer with Internet or unable to use a computer with Internet provided by the study
- Participated in the development and refinement of the CCC Workshop (prospective exemption X14-006)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Allison Applebaum, PhD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2014
First Posted
September 26, 2014
Study Start
September 1, 2014
Primary Completion
August 1, 2018
Study Completion
August 1, 2018
Last Updated
August 10, 2018
Record last verified: 2018-08